This September, for Gynecologic Cancer Awareness Month, we are spotlighting the innovative discoveries supported through GCI Internal Awards that are accelerating progress in research and care.
Meet Dr. Alex Lukey, co-investigator on the project, “The acceptability of risk-reducing salpingectomy for people at high lifetime risk for ovarian cancer: A mixed methods study of people and providers,” led by Principal Investigator Dr. Gillian Hanley and supported through the GCI Clinical Trials Group Accelerating Grants Program (2023-2025).
GCI sincerely acknowledges the support of the North Family Foundation, through the VGH & UBC Hospital Foundation and administered through OVCARE, for the Clinical Trials Group Accelerating Grants Program.
Learn more about this work in the referenced publications:
- Evaluating Ovarian Cancer Risk–Reducing Salpingectomy Acceptance: A Survey
- Risk-reducing salpingectomy: Considerations from an OBGYN perspective
Follow along throughout September for more research stories and impact highlights.
Stay in the loop with the Gynecologic Cancer Initiative: